The U.S. Food and Drug Administration approved Novartis AG’s injectable drug, Cosentyx, to treat adults with a moderate to severe…
Read MoreThe U.S. Food and Drug Administration approved Novartis AG’s injectable drug, Cosentyx, to treat adults with a moderate to severe…
Read MoreA woman who had previously battled melanoma was terrified when she saw a new brown mark on her heel. Although…
Read MoreYoung survivors of nonmelanoma skin cancer – the most common form of skin cancer – are at an increased risk…
Read More